CDK20 and ovarian carcinoma: CDK20 also known as CCRK, which has sequence homology to CDK7, represents a novel cell cycle-related kinase (CAK) activity, and controls cell cycle progression [46] in various cancers including lung [47], colorectal, liver and ovarian cancer [36, 48-50].